Armata Pharmaceuticals, Inc. (FRA:TG1N)
Germany · Delayed Price · Currency is EUR 6.65
+0.40 (6.40%)
At close: Jan 9, 2026
Armata Pharmaceuticals Market Cap
Armata Pharmaceuticals has a market cap or net worth of €220.66 million as of January 9, 2026. Its market cap has increased by 226.83% in one year.
Market Cap
220.66M
Enterprise Value
360.73M
Revenue
4.31M
Ranking
n/a
PE Ratio
n/a
Stock Price
€6.65
Market Cap Chart
Since May 10, 2019, Armata Pharmaceuticals's market cap has increased from 41.20M to 220.66M, an increase of 435.62%. That is a compound annual growth rate of 28.59%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 220.66M | 13.32% |
| Dec 31, 2025 | 194.73M | 201.18% |
| Dec 31, 2024 | 64.66M | -38.98% |
| Dec 29, 2023 | 105.95M | 152.65% |
| Dec 30, 2022 | 41.94M | -67.87% |
| Dec 31, 2021 | 130.52M | 186.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 10, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 247.30B |
| Siemens Aktiengesellschaft | 197.59B |
| Allianz SE | 145.37B |
| Deutsche Telekom AG | 134.99B |
| Siemens Energy AG | 107.65B |
| Rheinmetall AG | 87.17B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 67.47B |
| Deutsche Bank Aktiengesellschaft | 63.01B |